We’re proud to
partner with healthcare
professionals and companies that share
our focus on helping
patients live better lives.

We have recently entered into a successful collaboration in the surgical space:

Durect Corporation: Licensing agreement for exclusive development and commercialization rights to POSIMIR® (bupivacaine solution) for infiltration use

We continue looking to build our company through the in-licensing or acquisition of registration phase and on-market therapies to increase our presence in the US acute care and specialty therapeutic areas.